Frequency Exchange Corp. Launches Worldwide Digital Premiere of Superhuman 2: The Rebirth Featuring NIKKI Wellness Technology

Vancouver, British Columbia, Canada — October 30, 2026 — Leads & Copy — Frequency Exchange Corp. (“Frequency Exchange” or the “Company”) is launching the worldwide digital premiere of its new four-part docuseries, Superhuman 2: The Rebirth, which prominently features NIKKI Wellness Technology, the Company’s flagship frequency-based wellness platform and wearable device. The series, from award-winning filmmaker Caroline Cory, begins its digital release today, October 30, 2026, following its debut at the DaVinci International Film Festival on September 26 and a global premiere in Beverly Hills on October 4.

Superhuman 2: The Rebirth explores emerging perspectives on human potential, perception, and cognitive performance, utilizing research-driven insights from subject matter experts. The worldwide online premiere commenced at 12:00 P.M. PST with live conversations and Q&A sessions. Stephen Davis, CEO of Frequency Exchange and founder of NIKKI Technology, participated in a live conversation and Q&A prior to the docuseries screening. Tickets for the online event, granting seven-day access to the complete series, are available at watch.superhuman2.com.

“Today’s worldwide digital premiere represents an important visibility milestone for NIKKI and Frequency Exchange,” stated Stephen Davis. “NIKKI’s prominent integration throughout Superhuman 2: The Rebirth, together with my participation in the live premiere, introduces the technology and our story to an international audience as we continue advancing our broader commercialization and market awareness strategies.”

The global digital release is expected to provide international exposure for NIKKI as Frequency Exchange continues to advance its commercialization efforts across North America, the Middle East, and other international markets. Further details on the premiere and the docuseries can be found at watch.superhuman2.com and wearenikki.com/superhuman.

In parallel with its commercialization initiatives, Frequency Exchange has closed the second and final tranche of its previously announced Non-Brokered Private Placement. The Company issued an additional 241,131 units at $0.25 per unit, raising $60,282.75. This brings the total aggregate proceeds from the Private Placement to $487,340.25, comprising 1,949,361 units. Each unit includes one common share and one-half of a common share purchase warrant. The warrants are exercisable at $0.40 for 12 months and are subject to an acceleration clause tied to trading price performance on the TSX Venture Exchange.

The Company also issued 8,000 non-transferable finder’s warrants and paid a $2,000 cash commission to Research Capital Corp. These finder’s warrants are also exercisable at $0.40 for 12 months and share the same acceleration clause. All securities issued in connection with the final tranche are subject to a statutory hold period extending until March 1, 2027. The net proceeds from the Private Placement are designated for expansion of sales and marketing, inventory increase, technology and platform development, team growth, international expansion support, and general working capital. The Private Placement is pending final approval from the TSX Venture Exchange.

Superhuman 2: The Rebirth is a four-part docuseries by Caroline Cory that investigates emerging scientific perspectives on human potential, perception, and cognitive performance. The series utilizes structured experiments and interviews to examine phenomena that challenge conventional models of cognition and sensory processing, offering viewers a research-driven look at evolving wellness approaches. NIKKI Wellness Technology is featured to provide context on frequency-based wellness programs.

Frequency Exchange Corp. is a technology company developing wearable digital wellness solutions through its platform, NIKKI. NIKKI offers personalized frequency-based wellness programs to support sleep, stress, recovery, energy, and overall wellbeing, evolving from research initially supporting individuals with Lyme disease. The platform is designed to address significant global health challenges.

Source: Frequency Exchange Corp.